Lateral Flow Assays Market Trends, Growth, Size, Revenue, Challenges and Future Outlook
Lateral Flow Assays Market Size- By Product, By Application, By Technique, By Test-type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Aug-2021 | Report ID: MEDE2106 | Pages: 1 - 285 | Formats*: |
| Category : Medical Devices | |||
Lateral Flow Assays Market Introduction and Overview
According to SPER Market Research, the Global Lateral Flow Assays Market is estimated to reach USD 24.47 billion by 2034 with a CAGR of 7.81%.
Lateral flow assays are widely used to detect the presence of specific target components in liquid samples without the need for expensive or specialized equipment. These tests offer a simple, cost-effective solution for rapid detection. The increasing prevalence of infectious diseases is expected to significantly contribute to the growth of the lateral flow assays market. As the demand for quick, reliable diagnostics rises, particularly in point-of-care settings, the market for lateral flow assays is anticipated to experience substantial growth during the forecast period, driven by advancements in medical testing technology. However, the market growth is slowed by strict and lengthy rules for tests that detect specific substances. Also, many healthcare professionals are reluctant to change current medical practices, which makes it harder for new testing methods to be widely adopted, limiting the growth of the lateral flow assays market.
- Abbott Laboratories was granted FDA Emergency Use Authorization (EUA) in February 2022 for its Alinity M assay, which detects antibodies to SARS-CoV-2.
- Roche introduced the next generation of SARS-CoV-2 fast antigen testing, or "2.0," in October 2022.
By Product: Based on product, kits and reagents accounted for the largest revenue share.
In 2022, kits and reagents accounted for the largest revenue share, as these lateral flow kits offer greater flexibility in detecting various analytes without needing to spray antibodies on the test strip. Their versatility extends to pharmaceuticals, animal health, environmental testing, food, feed, and plant testing. The introduction of new kits by major companies is expected to drive market growth during the forecast period. It is anticipated that lateral flow readers would grow significantly throughout the course of the forecast period. These readers are inexpensive, simple to use, and deliver precise readings in a matter of minutes. The market for lateral flow assays is anticipated to rise as a result of increased strategic initiatives by market participants. For instance, Eurofins Technologies introduced the RapidScan ST5-W lateral flow reader in December 2021. This device was created especially for quick environmental and food testing.
By Application: The clinical testing segment of the Lateral Flow Assays Market is expected to grow at a significant rate.
In 2022, the clinical testing segment dominated the market with a 77% share, largely due to the rising prevalence of infectious diseases. This segment includes various types of clinical testing, such as infectious diseases, cardiac marker testing, cholesterol/lipid testing, pregnancy & fertility testing, drug abuse testing, and others. The growing risk of infectious and pathogen-related diseases is driving the demand for rapid diagnostic tools like lateral flow assays. The drug development and quality testing segment is anticipated to experience the fastest growth. Lateral flow assays are increasingly used in therapeutic drug monitoring, offering a cost-effective and efficient way to detect multiple markers in various samples. The availability of antibiotic tests, such as Charm ROSA lateral flow assays, also supports market growth by providing reliable and regulated detection methods for substances in dairy cow milk.
By Technique: Based on Technique, it is anticipated that sandwich assays will account for the largest portion of revenue.
Sandwich assays are projected to have the largest revenue share of 39. 35% in 2022 due to their accuracy, cost-effectiveness, and user-friendliness. They can be utilized in low-resource healthcare environments without needing trained staff.
By Test-type: The lateral flow immunoassay segment dominated the market.
The lateral flow immunoassay segment had a revenue share of 64. 60% in 2022. These tests are used in various healthcare settings for detecting antibodies and antigens. They are easy to perform, low-cost, and widely applicable for disease screening, monitoring, and diagnosis, usable by health staff and patients at home.
By End Use: based on end use, hospitals & clinics segment held the largest market share.
Hospitals and clinics currently dominate the market for holding the largest share in 2022 at 35.70%. This significant reliance on these primary care settings is driven by the growing demand for enhanced diagnostic services and increasing global healthcare expenditure.
Throughout the projected period, the category of pharmaceutical and biotechnology firms is expected to increase at the fastest rate. This growth is attributed to strategic initiatives undertaken by these companies, including mergers and acquisitions, robust research and development efforts, successful product approvals and launches, and expansion of their global operations. Emerging players in this segment are actively pursuing collaborations to enhance their offerings in lateral flow tests.
By Region: The greatest market share for Lateral Flow Assays is held by the North America region.
North America boasts the highest healthcare spending globally, leading to substantial investments in advanced ophthalmic technology. This significant investment fosters the development and adoption of cutting-edge solutions for both vision prevention and restoration. The region is home to world-renowned research institutions and medical centers at the forefront of ocular research and development. This dynamic environment nurtures innovation, resulting in a continuous stream of new and improved ophthalmic equipment entering the market.
Market Competitive Landscape
The Global Lateral Flow Assays Market is highly consolidated. Some of the market players are Abbott Laboratories, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN N.V., Quidel Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Application, By Technique, By Test-type, By End Use. |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. |
| Companies Covered | Abbott Laboratories, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN N.V., Quidel Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., Others. |
Key Topics Covered in the Report:
- Global Lateral Flow Assays Market Size (FY’2025-FY’2034)
- Overview of Global Lateral Flow Assays Market
- Segmentation of Global Lateral Flow Assays Market By Product (Kits & Reagents, Lateral Flow Readers)
- Segmentation of Global Lateral Flow Assays Market By Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing)
- Segmentation of Global Lateral Flow Assays Market By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays)
- Segmentation of Global Lateral Flow Assays Market By Test-type (Lateral Flow Immunoassay, Nucleic Acid Lateral Flow Assay)
- Segmentation of Global Lateral Flow Assays Market By End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care, Pharmaceutical & Biotechnology Companies, Others)
- Statistical Snap of Global Lateral Flow Assays Market
- Expansion Analysis of Global Lateral Flow Assays Market
- Problems and Obstacles in Global Lateral Flow Assays Market
- Competitive Landscape in the Global Lateral Flow Assays Market
- Details on Current Investment in Global Lateral Flow Assays Market
- Competitive Analysis of Global Lateral Flow Assays Market
- Prominent Players in the Global Lateral Flow Assays Market
- SWOT Analysis of Global Lateral Flow Assays Market
- Global Lateral Flow Assays Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Lateral Flow Assays Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Lateral Flow Assays Market
7. Global Lateral Flow Assays Market, By Product (USD Million) 2025-2034
7.1. Kits & Reagents7.2. Lateral Flow Readers
7.2.1. Lateral Flow Readers7.2.2. Benchtop Readers7.2.3. Digital Readers
8. Global Lateral Flow Assays Market, By Application (USD Million) 2025-2034
8.1. Clinical Testing
8.1.1. Infectious Disease Testing8.1.2. Cardiac Maker Testing8.1.3. Pregnancy & Fertility Testing8.1.4. Cholesterol Testing/Lipid Profile8.1.5. Drugs of Abuse Testing8.1.6. Others
8.2. Veterinary Diagnostics8.3. Food Safety & Environment Testing8.4. Drug Development & Quality Testing
9. Global Lateral Flow Assays Market, By Technique (USD Million) 2025-2034
9.1. Sandwich Assays9.2. Competitive Assays9.3. Multiplex Detection Assays
10. Global Lateral Flow Assays Market, By Test-type (USD Million) 2025-2034
10.1. Lateral Flow Immunoassay10.2. Nucleic Acid Lateral Flow Assay
11. Global Lateral Flow Assays Market, By End Use (USD Million) 2025-2034
11.1. Hospitals & Clinics11.2. Diagnostic Laboratories11.3. Home Care11.4. Pharmaceutical & Biotechnology Companies11.5. Others
12. Global Lateral Flow Assays Market Forecast, 2025-2034 (USD Million)
12.1. Global Lateral Flow Assays Market Size and Market Share
13. Global Lateral Flow Assays Market, By Region, 2025-2034 (USD Million)
13.1. Asia-Pacific
13.1.1. Australia13.1.2. China13.1.3. India13.1.4. Japan13.1.5. South Korea13.1.6. Rest of Asia-Pacific
13.2. Europe
13.2.1. France13.2.2. Germany13.2.3. Italy13.2.4. Spain13.2.5. United Kingdom13.2.6. Rest of Europe
13.3. Middle East and Africa
13.3.1. Kingdom of Saudi Arabia13.3.2. United Arab Emirates13.3.3. Qatar13.3.4. South Africa13.3.5. Egypt13.3.6. Morocco13.3.7. Nigeria13.3.8. Rest of Middle-East and Africa
13.4. North America
13.4.1. Canada13.4.2. Mexico13.4.3. United States
13.5. Latin America
13.5.1. Argentina13.5.2. Brazil13.5.3. Rest of Latin America
14. Company Profile
14.1. Abbott Laboratories
14.1.1. Company details14.1.2. Financial outlook14.1.3. Product summary14.1.4. Recent developments
14.2. BD
14.2.1. Company details14.2.2. Financial outlook14.2.3. Product summary14.2.4. Recent developments
14.3. Bio-Rad Laboratories, Inc.
14.3.1. Company details14.3.2. Financial outlook14.3.3. Product summary14.3.4. Recent developments
14.4. bioMérieux SA
14.4.1. Company details14.4.2. Financial outlook14.4.3. Product summary14.4.4. Recent developments
14.5. Danaher Corporation
14.5.1. Company details14.5.2. Financial outlook14.5.3. Product summary14.5.4. Recent developments
14.6. F. Hoffmann-La Roche AG
14.6.1. Company details14.6.2. Financial outlook14.6.3. Product summary14.6.4. Recent developments
14.7. Hologic, Inc.
14.7.1. Company details14.7.2. Financial outlook14.7.3. Product summary14.7.4. Recent developments
14.8. Merck KGaA
14.8.1. Company details14.8.2. Financial outlook14.8.3. Product summary14.8.4. Recent developments
14.9. PerkinElmer, Inc.
14.9.1. Company details14.9.2. Financial outlook14.9.3. Product summary14.9.4. Recent developments
14.10. QIAGEN N.V.
14.10.1. Company details14.10.2. Financial outlook14.10.3. Product summary14.10.4. Recent developments
14.11. Quidel Corporation
14.11.1. Company details14.11.2. Financial outlook14.11.3. Product summary14.11.4. Recent developments
14.12. Siemens Healthineers
14.12.1. Company details14.12.2. Financial outlook14.12.3. Product summary14.12.4. Recent developments
14.13. Thermo Fisher Scientific, Inc.
14.13.1. Company details14.13.2. Financial outlook14.13.3. Product summary14.13.4. Recent developments
14.14. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The presence or absence of a target analyte in a sample is determined using lateral flow assays, also referred to as lateral flow immunoassays or lateral flow tests.
Lateral Flow Assays Market is projected to reach USD 24.47 billion by 2034, growing at a CAGR of 7.81% during the forecast period.
Lateral Flow Assays Market grew in market size from 2025. The Market is expected to reach USD 24.47 billion by 2034, at a CAGR of 7.81% during the forecast period.
Lateral Flow Assays Market CAGR of 7.81% during the forecast period.
You can get the sample pages by clicking the link -Click Here
Lateral Flow Assays Market size is USD 24.47 billion from 2025 to 2034.
Lateral Flow Assays Market Segment is Covered By Product, By Application, By Technique, By Test-type, By End Use.
The North America region is anticipated to have the highest market share in Lateral Flow Assays Market.
The key players in the market include Companies Covered Abbott Laboratories, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN N.V., Quidel Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., Others.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
